References
- Ramachandran A. Know the signs and symptoms of diabetes. Indian J Med Res. 2014;140:579–581.
- Priyanka P, M, Panagal P, Sivakumar V, et al. Identification, expression, and methylation of miR-7110 and its involvement in type 1 diabetes mellitus. Gene Reports. 2018;11:229–234.
- Animaw W, Seyoum Y. Increasing prevalence of diabetes mellitus in a developing country and its related factors. PLoS One. 2017;12:e0187670.
- Campbell R. Type 2 diabetes: where we are today: an overview of disease burden, current treatments, and treatment strategies. J Am Pharm Assoc. 2009;49: S5–S9.
- Levitt NS. Diabetes in Africa: epidemiology, management and healthcare challenges. Heart. 2008;94:1376–1382.
- Hall V, Thomsen R, Henriksen O, et al. Diabetes in Sub Saharan Africa 1999–2011: epidemiology and public health implications. A systematic review. BMC Public Health. 2011;11:564.
- Sekar D, Venugopal B, Sekar P, et al. Role of microRNA 21 in diabetes and associated/related diseases. Gene. 2016;582:14–18.
- Panagal M, Biruntha M, Vidhyavathi RM, et al. Dissecting the role of miR-21 in different types of stroke. Gene. 2019;681:69–72.
- Sekar D. Comment on the potential role of microRNAs in hypertension. J Hum Hypertens. 2018;32:639–640.
- Shincy JS, Panagal M, Jereena J, et al. Computational Identification of microRNA-17-3p in breast cancer cells. MIRNA. 2017;6:208–212.
- Sekar D, Krishnan R, Panagal M, et al. Deciphering the role of microRNA 21 in cancer stem cells (CSCs). Genes Dis. 2016;3:277–281.
- McLean MP, Billheimer JT, Warden KJ, et al. Differential expression of hepatic sterol carrier proteins in the streptozotocin-treated diabetic rat. Endocrinology. 1995;136:3360–3368.
- Lujambio A, Esteller M. How epigenetics can explain human metastasis: a new role for microRNAs. Cell Cycle. 2009;8:377–382.
- Krishnan R, Mani P, Sivakumar P, et al. Expression and methylation of circulating microRNA-510 in essential hypertension. Hypertens Res. 2017;40:361–363.